NCT05328115 2025-01-31
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
Alzinova AB
Phase 1 Completed
Clinical Trials
3 trialsNCT02859207 2017-06-08
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Eisai Inc.
Phase 1 Completed
NCT00411580 2013-03-29
Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)
Novartis
Phase 1 Completed